 |
Journal articles
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
Valentina Poletti
1
Fabrizia Urbinati
Sabine Charrier
Guillaume Corre
2
Roger Hollis
Beatriz Campo Fernandez
Samia Martin
3
Michael Rothe
Axel Schambach
Donald Kohn
Fulvio Mavilio
3
Valentina Poletti 1
Author
Fabrizia Urbinati
Author
Sabine Charrier
Author
Guillaume Corre 2
Author IdHAL : guillaume-corre ResearcherId : http://www.researcherid.com/rid/T-9696-2019 ORCID : https://orcid.org/0000-0002-0755-8336
1
UNIMORE - Università degli Studi di Modena e Reggio Emilia ( 41121 Modena / 42121 Reggio Emilia - Italy)
2
INTEGRARE - Approches génétiques intégrées et nouvelles thérapies pour les maladies rares (1 bis rue de l'Internationale, 91002 Évry Cedex - France)
- EPHE - École pratique des hautes études (4-14 Rue Ferrus, 75014 Paris - France)
- PSL - Université Paris sciences et lettres (60 rue Mazarine 75006 Paris - France)
- UEVE - Université d'Évry-Val-d'Essonne (Boulevard François Mitterrand 91025 Evry Cedex - France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : UMR_S951 (101, rue de Tolbiac, 75013 Paris - France)
- Généthon (1 rue de l’Internationale, 9100 Evry - France)
3
Généthon (1 rue de l’Internationale, 9100 Evry - France)
Document type :
Journal articles
Complete list of metadata
https://hal-univ-evry.archives-ouvertes.fr/hal-02178306
Contributor : Guillaume Corre <>
Submitted on : Tuesday, July 9, 2019 - 4:41:08 PM
Last modification on : Saturday, July 3, 2021 - 12:16:52 AM
Contributor : Guillaume Corre <>
Submitted on : Tuesday, July 9, 2019 - 4:41:08 PM
Last modification on : Saturday, July 3, 2021 - 12:16:52 AM
Links full text
Identifiers
- HAL Id : hal-02178306, version 1
- DOI : 10.1016/j.omtm.2018.10.014
Collections
UNIV-EVRY | INTEGRARE | EPHE | PSL | GS-HEALTH-DRUG-SCIENCES
Citation
Valentina Poletti, Fabrizia Urbinati, Sabine Charrier, Guillaume Corre, Roger Hollis, et al.. Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease. Molecular Therapy - Methods and Clinical Development, Nature Publishing Group, 2018, 11, pp.167-179. ⟨10.1016/j.omtm.2018.10.014⟩. ⟨hal-02178306⟩
Metrics
Record views
